Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

Sarah A. Holstein, Philip L. McCarthy, Paul G. Richardson et al.|The Lancet Haematology|2017

Cited by 172